Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progressive Orexin Deficiency and Age-Dependent Glial and Axonal Biomarkers in juvenile neuronal ceroid lipofuscinosis type 3 (CLN3) Disease.

Pediatric neurology·2026
Same author

A Nationwide Study of Pyruvate Dehydrogenase Complex Deficiency in Sweden: Epidemiology, Genotype-Phenotype Correlations, and Survival.

Neurology·2026
Same author

Living with Duchenne muscular dystrophy as an adult: motor function, ventilatory assistance and health-related quality of life.

Neuromuscular disorders : NMD·2026
Same author

Age-related differences in hot and cold executive functions in boys with Duchenne muscular dystrophy: longitudinal individual changes and age-group comparisons across childhood and adolescence.

Neuromuscular disorders : NMD·2025
Same author

Liver Involvement in POLG Disease-a Multicentre Cohort Study of 202 Patients.

Journal of inherited metabolic disease·2025
Same author

Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical Trial.

European journal of neurology·2025

Related Experiment Video

Updated: Jul 19, 2026

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy.

Eva L Arkblad1, Niklas Darin, Kerstin Berg

  • 1Department of Clinical Genetics, Sahlgrenska University Hospital/East, Göteborg, Sweden. eva.arkblad@vgregion.se

Neuromuscular Disorders : NMD
|October 20, 2006
PubMed
Summary

Multiplex ligation-dependent probe amplification (MLPA) enhances spinal muscular atrophy (SMA) diagnostics by detecting novel SMN1 gene deletions. This method identified previously unreported partial SMN1 deletions in Swedish families, improving SMA genetic diagnosis.

More Related Videos

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

Related Experiment Videos

Last Updated: Jul 19, 2026

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Spinal muscular atrophy (SMA) is an autosomal recessive disorder linked to reduced survival motor neuron protein (SMN).
  • SMN1 gene absence is the primary cause of SMA in most cases.
  • Conventional diagnostic methods may not detect all SMN1 gene alterations.

Purpose of the Study:

  • To evaluate the utility of Multiplex Ligation-dependent Probe Amplification (MLPA) in diagnosing SMA.
  • To identify novel genetic mutations in SMN1 associated with SMA.
  • To illustrate the clinical and genetic diversity of SMA.

Main Methods:

  • Utilized MLPA, a quantitative molecular technique, for simultaneous copy number analysis of SMN1 and nearby genes.
  • Applied MLPA in clinical diagnostics for SMA patients.
  • Collected clinical data and MLPA results from patients representing various SMA types and genetic profiles.

Main Results:

  • Identified a previously unreported partial deletion of SMN1 (exons 1-6) in two unrelated Swedish families using MLPA.
  • MLPA detected mutations missed by conventional diagnostic approaches.
  • Reported diverse SMA cases, including homozygous SMN1 absence with one SMN2, an asymptomatic individual with five SMN2 copies, and patients with SMA types 1, 2, and 3.

Conclusions:

  • MLPA is a valuable tool for comprehensive SMA genetic diagnostics, capable of detecting complex SMN1 deletions.
  • The study highlights the broad spectrum of SMA genetics and clinical presentations.
  • Improved diagnostic capabilities through advanced molecular methods like MLPA are crucial for understanding and managing SMA.